Issue 23 | 2015
Get instant access to latest e-book

latest newsRead more...

12

Feb 2016

Teva Says Actavis Deal to Close by April as Profit Falls

Teva Pharmaceutical Industries the worlds largest generics drugmaker reported a fall in fourthquarter profit and revenue on lower sales of its top drug and said it expects to close its purchase of Actavis by early April Israelbased Teva TEVAN agreed last year to buy Allergans AGNN Actavis ..

12

Feb 2016

South Africa Sets Up State-Owned Pharmaceutical Firm - Zuma

South Africa has set up a stateowned pharmaceutical company that would compete with local firms in supplying medicines to public hospitals President Jacob Zuma said in his state of the nation address on Thursday Health authorities in one of the worlds biggest market for antiretroviral drugs have long complained they were paying too much to secure ..

12

Feb 2016

Air Liquide's Arm Cryo Buys Pharma Logistics Firm PDP Couriers

Cryo International an Air Liquide group subsidiary specialising in temperaturecontrolled logistics solutions has acquired PDP Couriers a major player in the customised transport of high valueadded products for the pharmaceutical and biotechnology industries Based in the UK PDP Couriers has over employees at location..

12

Feb 2016

Innovus Pharmaceuticals Agrees to Acquire All of Beyond Human, LLC's Products

Innovus Pharmaceuticals Inc a company focusing on the commercialization of overthecounter OTC and consumer products for mens and womens health vitality and respiratory diseases announced today the signing of a definitive asset purchase agreement with Beyond Human LLC a Texas limited liability company Beyond Human to ac..

eventsRead more...

12 - 14

Feb 2016

Midwest Pharmacy Expo

Iowa Pharmacy Association
Iowa Events Center

15 - 19

Feb 2016

ICTR-PHE 2016

CERN
CICG Geneva

12

Feb 2016

Unveiling the 9th PPM Conference

Fleming is one of the largest producers of PharmaB..

11

Feb 2016

Proliant Biologicals Opens New Zealand Facility

ANKENY Iowa Feb PRNewswire Proliant Biological..

TOP ARTICLES

knowledge bank

  • interviews

    ExpreS2ion Biotechnologies

    Vice President - Business Development
    ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated i..

  • Articles

    Better ways to handle tablets using IBCs

    Still handling tablets in drums It is common to find Intermediate Bulk Containers IBCs being used for handling powders and granules in solid dosage manufacturing processes from initial Dispensing through to Tablet Compression or Capsule Filling The benefits of using IBCs for efficient and flexible materials handling at this stage of the process are widely appreciated and applied in modern facilit..

  • Research Insights

    Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

    Abstract In December of chikungunya virus CHIKV an alphavirus in the family Togaviridae was introduced to the island of Saint Martin in the Caribbean resulting in the first autochthonous cases reported in the Americas As of January local and imported CHIKV has been reported in American countries with over million suspected cases CHIKV causes a severe arthralgic disease for which there are no approved vaccines or therapeutics Furthermore the ..

editorial Section

  • Strategy

    Bioprinting

    The bioprinting of tissues and organs has been big news recently However the patenting of bioprinting techniques has quietly been going on for years This article will discuss the patents covering the three process phases of bioprinting the exceptions to patent infringement for experimental uses and the prospects for further patenting and patent infringement lawsuits..

  • Research Developement

    Rethinking Drug Discovery

    The quest to undertake biological targets that are based on the regulation of signalling pathways is challenging the classical thinking in the drug discovery arena Historically the complexity of the biological system was underestimated It is now wellaccepted that compared to old biological targets that were focused on single gene or gene products we need to undertake targets that are derived from complex and dynamic signaling pathways..

  • Clinical Trails

    Issues & Concerns in Conducting Clinical Trials in India

    Issues like approval delays deficiencies of functioning of CROs and other stake holders liabilities and compensation to injured subjects insurance issues etc still remain in India which has made multinational companies to rethink on opting for India to conduct clinical trials in India recently There is a need for a law to ensure that the people who undergo clinical trials are not exploited and should be well informed about risk as well to provide..

  • Manufacturing

    Validation Projects in China

    This article is a firsthand account of the experiences of Pharmadule in guiding leading Chinese manufacturers through facility investment projects aimed at compliance with Chinese US and EU GMP requirements These manufacturers have been among the first in the world to fully embrace the work procedures outlined in ICH Q Q and Q Implementing these guidelines in large organisations would be a challenge with any global market but it turns out that the Chinese market offers both advantages and cultur..

  • Information Technology

    Quality by Design

    The article presents a novel approach to applying Quality by Design QbD principles to the development of analytical methods Common critical parameters in HPLC gradient time temperature pH of the aqueous eluent and stationary phase are evaluated within the Quality by Design framework It is useful for the robust analytical method development and Design Space optimisation..

  • Expert Talk

    Peptides Remain a Growth Story

    Cloud solutions offer immediate returns in improving operational performance and reducing costs Multiple approaches to cloud solutions will be needed to satisfy life science industry needs complicating the development of a coherent cloud strategy..

TOP